Oncology & Cancer

Genomic profiling for cancer of unknown primary site

Genomic profiling of cancer of an unknown primary site (CUP) found at least one clinically relevant genomic alteration in most of the samples tested, an indication of potential to influence and personalize therapy for this ...

Genetics

Your immune system: On surveillance in the war against cancer

Predicting outcomes for cancer patients based on tumor-immune system interactions is an emerging clinical approach, and new research from Wake Forest Baptist Medical Center is advancing the field when it comes to the most ...

Genetics

Novel analysis method organizes genomic cancer data

The technology that allows scientists to profile the entire genome of individual tumors offers new hope for discovering ways to select the best treatment for each patient's particular type of cancer. However, these profiles ...

Oncology & Cancer

Genomic sequencing offers new hope for rare cancers

A cancer's genetic sequence may be the key to matching people with rare cancers to the right anti-cancer treatments, according to a new clinical trial instigated by patients.

Other

Roche buys US Foundation Medicine for $2.4 bn

Swiss pharmaceutical giant Roche said Tuesday it had reached an agreement to purchase the remaining shares of US lab Foundation Medicine, of which it already holds a majority stake, for $2.4 billion.

page 3 from 3